HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Processing Removes 'Natural' Claim For UK Meal-Replacement Bar Ingredients

This article was originally published in The Rose Sheet

Executive Summary

UK firm contends processing ingredients into edible form is common across food and nutritional products industries and many foods consumers use regularly contains ingredients that long have been processed for use. Advertising Standards Authority points out a UK Food Standards Agency guidance explained that the use of solvents or other chemicals in processing disqualifies most processed ingredients from labeling as natural.

You may also be interested in...



Essential Oil Sleep Claims In Hot Water With UK Advertising Regulator

UK Advertising Standards Authority advised Puressentiel not to make ad claims reserved for licensed medicinal products. Puressentiel argued its products aren't medicinal, but still provided efficacy studies, which ASA declined to review.

Skinny Tan Ad Claims Went Several Shades Too Far For UK Authority

UK ad authority tells InnovaDerma UK Ltd. to stop referring to its Skinny Tan sunless tanning product as “No. 1,” “natural,” free of DHA, better smelling than other sunless tanning products, or as a way to reduce the appearance of cellulite.

Waiting For FDA: Federal Courts Debate Stays Of 'Natural' Class Actions

Mayer Brown attorney Dale Giali discusses the "natural" litigation landscape, where litigants increasingly are sparring over the appropriateness of stays in light of FDA's comment-gathering initiative launched in 2015.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS121513

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel